Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-Ab™
Target-Humanized Mouse Models (HUGO-GT™)
Target-Humanized Mouse Models (CDS)
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Custom Model Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Preclinical Solutions
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic
Obesity
MASH & MASLD
Cardiovascular
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Retinal-related diseases
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Systemic Lupus Erythematosus
Drug Classification
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
iCyagen
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Company Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login

SLE Mouse Models & Preclinical CRO Services

Explore Cyagen's preclinical solutions for systemic lupus erythematosus (SLE) research, including pristane- and IMQ-induced mouse models, in vivo pharmacology, autoimmune biomarker analysis, and renal histopathology to support therapeutic development and translational research.
HomeCRO ServicesSLE Mouse Models & Preclinical CRO Services

Why Preclinical SLE Models Matter

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies, immune complex deposition, and systemic inflammation affecting multiple organs, particularly the kidneys, skin, and joints. Lupus nephritis (LN), one of the most serious manifestations of SLE, remains a major challenge in disease management and therapeutic development.

SLE pathogenesis involves complex interactions among innate and adaptive immune responses, including dysregulated B-cell activation, autoantibody production, Toll-like receptor 7 (TLR7) signaling, and type I interferon pathways. These interconnected mechanisms contribute to immune dysregulation, organ-specific inflammation, and, in some cases, tissue damage.

Given the heterogeneity of SLE and its diverse clinical manifestations, selecting appropriate preclinical models is essential for investigating disease mechanisms and evaluating novel therapies. Well-characterized animal models provide model-dependent readouts, such as serum autoantibody levels, renal histopathological changes, and selected inflammatory markers, to support mechanistic research and preclinical efficacy assessment.

{{ static_tabs[0].title }}
Cyagen provides experimentally characterized induced SLE mouse models to support autoimmune disease research and therapeutic evaluation. Our pristane- and IMQ-induced models offer complementary approaches to studying systemic autoimmunity, lupus-associated renal pathology, and pharmacological responses.

Disease-Relevant Induced SLE Models

Cyagen provides experimentally characterized induced lupus-like mouse models to support systemic lupus erythematosus (SLE) research. Our pristane- and IMQ-induced models offer complementary approaches for investigating autoimmune responses, evaluating disease-associated phenotypes, and supporting preclinical pharmacology studies.
Model Mouse Platform Application Action
Pristane-Induced Lupus-Like Mouse Model BALB/c mice Investigate long-term lupus-like autoimmune responses and characterize serum anti-dsDNA antibodies, lymphoid organ alterations, and renal histopathological findings. View Study
IMQ-Induced Lupus-Like Mouse Model BALB/c mice Study TLR7-associated autoimmune responses and evaluate pharmacological effects using serological biomarkers, renal injury-associated endpoints, and histopathological assessments. View Study

Featured Model: MRL/MpJ-Fas-KO Mouse Model

Catalog Number Name Base Strain Research Application Action
C001602 MRL/MpJ-Fasem1/Cya MRL/MpJ Investigate systemic autoimmunity, lymphoproliferation, and progressive lupus-associated renal pathology. View Validation Data

Related Genetically Engineered Mouse Models

Cyagen offers genetically engineered mouse models, including knockout, knockin, conditional knockout, and humanized strains, to support target validation and pathway-specific immunology research.
Base Strain
Search for Models
Search
Catalog Number Name Base Strain Research Application Action
{{ value.product_num || "--" }} {{ value.product_name || "--" }} {{ value.product_strain || "--" }}
Inquire
+
Previous Page
Next Page
{{ static_tabs[1].title }}
Cyagen supports preclinical SLE drug discovery through disease model establishment, tailored treatment protocols, and integrated pharmacodynamic evaluation. Study designs can be adapted to the therapeutic mechanism of action, research objectives, and disease-specific endpoints.
Disease Model Selection & Customization
Established and customized animal models for SLE, rheumatoid arthritis, psoriasis, inflammatory bowel disease (IBD), and other autoimmune conditions.
Flexible Drug Administration
Tailored dosing routes, treatment schedules, and administration regimens based on therapeutic mechanisms and study objectives.
Disease-Specific Efficacy Evaluation
Integrated assessment of observable disease-related phenotypes, body weight, organ indices, disease-related biomarkers, and pathological changes to assess pharmacodynamic responses and preclinical efficacy.
{{ static_tabs[2].title }}
Cyagen provides integrated in vitro and ex vivo analytical services to support preclinical research in systemic lupus erythematosus (SLE) and other autoimmune diseases. Our capabilities include biomarker profiling, immune cell analysis, and histopathological assessment, helping researchers characterize disease-related immune responses, investigate underlying mechanisms, and evaluate therapeutic efficacy.
Analysis Category Specific Services Key Applications in SLE Research
Autoantibody Profiling Serum anti-dsDNA antibody assessment, including ELISA-based assays Evaluates autoimmune activity and treatment-associated changes in serological biomarkers
Renal Injury Biomarkers Urinary albumin-to-creatinine ratio (UACR) measurement Assessment of albuminuria and treatment-associated changes in renal involvement, supports evaluation of renal involvement and treatment response
Renal Histopathology H&E staining and histopathological assessment Characterizes glomerular injury, inflammatory infiltration, tubular damage, and renal tissue changes
Renal Immunohistochemistry Mouse IgG immunostaining Supports characterization of renal immunoglobulin localization and lupus-related kidney pathology
Immune Cell Profiling Flow cytometry for T-cell, B-cell, and other immune populations Supports mechanism-oriented assessment of immune regulation and cellular responses
Cytokine & Molecular Profiling ELISA, multiplex cytokine assays, qPCR, and Western blotting Supports investigation of inflammatory mediators and target-associated signaling pathways
Case Studies
Why Choose Cyagen?
Disease-Relevant SLE Mouse Models
Access characterized pristane- and IMQ-induced lupus-like mouse models with autoimmune and renal pathology readouts to support disease mechanism studies and preclinical therapeutic evaluation.
Integrated Preclinical CRO Capabilities
From in vivo pharmacology to autoimmune biomarker profiling and renal histopathology, Cyagen provides integrated solutions for evaluating disease-associated changes and therapeutic responses.
Flexible & Customized Study Designs
Tailored model selection, dosing regimens, and efficacy endpoints, supported by genetically engineered mouse platforms, to address diverse research objectives in SLE and other autoimmune diseases.
Related Resources
British Society for Immunology Congress 2026
EVENTS & WEBINARS
British Society for Immunology Congress 2026
View Details
RESOURCE VAULT
SITC 2026: Immune Mechanisms, Core Targets & Emerging Therapies
View Details
RESOURCE VAULT
NKG Immunodeficient Mice
View Details
British Society for Immunology Congress 2026
EVENTS & WEBINARS
British Society for Immunology Congress 2026
View Details
RESOURCE VAULT
SITC 2026: Immune Mechanisms, Core Targets & Emerging Therapies
View Details
RESOURCE VAULT
NKG Immunodeficient Mice
View Details
Request a Preclinical CRO Services Consultation
Partner with Cyagen to advance your preclinical studies. Share your project goals with us and receive customized support.
Inquiry Details
Main Area of Research
Service(s) of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCompany OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2026 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research